What challenge does unsubstantiated cost-effectiveness pose for telehealth?

Unsubstantiated cost-effectiveness poses a significant challenge for telehealth primarily because it hampers widespread adoption. When the cost-effectiveness of telehealth services is not well established, it raises concerns among stakeholders such as healthcare providers, payers, and policymakers. Without clear evidence demonstrating that telehealth is a financially viable option compared to traditional in-person healthcare, there may be reluctance to invest in the necessary technologies or integrate telehealth into existing systems. This uncertainty can lead to hesitance in utilization among healthcare providers and patients alike, ultimately slowing the progress and acceptance of telehealth services in the healthcare landscape.

In contrast, the other options do not align with the implications of unsubstantiated cost-effectiveness. For instance, it does not guarantee funding; often, funding decisions depend heavily on validated data indicating cost savings or health outcomes. Additionally, unsubstantiated cost-effectiveness does not simplify billing processes, as unclear financial models can complicate reimbursement policies. Lastly, it does not encourage patient engagement; without demonstrated value, patients may be less inclined to participate in telehealth services, undermining engagement efforts.